OPEN END TURBO OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Real-time Bid/Ask 05:07:00 31/05/2024 pm IST | ||
| 5.07 EUR / 5.13 EUR | +0.59% |
|
| Current month | -6.46% | ||
| 1 month | -6.46% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 5.04 | -0.59% |
| 30/24/30 | 5.07 | -1.74% |
| 29/24/29 | 5.16 | +0.19% |
| 28/24/28 | 5.15 | +2.59% |
| 27/24/27 | 5.02 | -0.79% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 04:11 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK6NAM |
| ISIN | DE000JK6NAM1 |
| Date issued | 02/04/2024 |
| Strike | 142.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.38 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.43 € |
|---|---|
| Lowest since issue | 4.48 € |
| Spread | 0.06 € |
| Spread % | 1.17% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
87.89
USD
Average target price
96.55
USD
Spread / Average Target
+9.85%
- Stock Market
- Certificates
- Certificat
